Health
Freiburg researchers receive ERC funding to develop and test immunostimulatory drug candidates – News-Medical.net
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000…
With the Proof of Concept funding line, the ERC grants recipients of ERC frontier research funds (Starting, Consolidator, Advanced or Synergy grants) with 150.000 Euro to develop promising ideas with commercial or societal potential to the proof of concept stage. With this funding, Olaf Groß and his team in the Metabolism and Inflammation Group at the Institute of Neuropathology of the Medical Center – University of Freiburg will test whether a new class of immune activating drugs they discovered…
-
Noosa News23 hours agoFranz Ferdinand: Australian Tour 2025
-
General17 hours agoDavid Littleproud’s own goal • Inside Story
-
Noosa News17 hours agoQueensland GP accused of rape, sexual assault and torture pleads for bail despite ‘disturbing’ allegations
-
Business23 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week